Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIDE-HD: Pridopidine Dose-Finding in Huntington's Disease
NCT02006472Phase 2Completed
- Sponsor
- Prilenia Therapeutics
- Start
- Feb 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of pridopidine in Huntington's disease (HD), sponsored by Prilenia Therapeutics. Started Feb 2014; status: completed.
02
Drugs
pridopidine
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT02006472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02006472.